基亞

+1.55 (+4.43%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

36.502,843成交張數–本益比3.44股價淨值比0.00%殖利率2026-09-11資料日期

毛利率、營業利益率、淨利率

單季;近十年

單季營收

億元

季度	營收(億)	營收年增	毛利(億)	毛利率	營業利益(億)	營業利益率	淨利率
2026Q2	2.8	-21.1%	1.7	60.4%	0.2	6.9%	-9.1%
2026Q1	2.6	-47.6%	1.4	53.2%	-0.7	-25.6%	-20.3%
2025Q4	3.3	-1.2%	1.9	57.1%	-1.6	-48.6%	-35.8%
2025Q3	4.0	-9.4%	1.6	41.6%	-0.4	-9.6%	-14.3%
2025Q2	3.6	1.9%	2.0	56.1%	-0.6	-16.2%	-10.5%
2025Q1	5.0	98.7%	3.0	60.9%	1.0	19.6%	20.5%
2024Q4	3.3	-10.9%	1.6	49.2%	-0.5	-16.1%	-34.5%
2024Q3	4.4	4.7%	2.3	52.7%	0.0	0.7%	-6.2%
2024Q2	3.5	72.3%	2.2	62.9%	-0.3	-7.9%	3.4%
2024Q1	2.5	53.0%	1.4	54.9%	-1.4	-55.4%	-30.1%
2023Q4	3.7	82.1%	2.1	57.3%	-5.5	-149.4%	-86.8%
2023Q3	4.2	136.9%	2.2	52.5%	-0.9	-20.5%	-11.3%
2023Q2	2.1	7.3%	1.1	52.5%	-3.5	-170.9%	-47.3%
2023Q1	1.6	-66.1%	0.8	47.6%	-2.4	-147.2%	-57.6%
2022Q4	2.0	-90.6%	-3.3	-162.8%	-7.4	-363.7%	-174.4%
2022Q3	1.8	-87.3%	0.8	46.5%	-3.9	-223.5%	-66.0%
2022Q2	1.9	9.6%	0.6	33.7%	-3.5	-182.9%	-64.1%
2022Q1	4.8	161.1%	2.7	56.3%	-1.8	-37.6%	-16.9%
2021Q4	21.8	1045.2%	14.7	67.7%	9.8	44.9%	3.5%
2021Q3	13.9	798.6%	9.2	66.1%	5.8	41.8%	4.6%
2021Q2	1.7	24.6%	0.8	43.3%	-5.0	-285.8%	-73.9%
2021Q1	1.9	41.7%	0.9	47.8%	-2.7	-144.7%	-34.5%
2020Q4	1.9	12.2%	1.0	50.8%	-2.8	-149.2%	-35.0%
2020Q3	1.5	39.6%	0.6	41.8%	-2.5	-163.3%	-71.8%
2020Q2	1.4	-15.6%	0.6	41.6%	-2.2	-153.3%	-64.3%
2020Q1	1.3	23.3%	0.4	32.7%	-1.6	-123.5%	-53.8%
2019Q4	1.7	146.6%	0.9	54.2%	-2.3	-134.9%	-83.2%
2019Q3	1.1	-0.3%	0.4	34.2%	-1.7	-157.3%	-78.5%
2019Q2	1.7	46.4%	0.9	53.7%	-1.8	-107.4%	34.0%
2019Q1	1.1	-7.0%	0.4	35.0%	-1.8	-170.9%	-79.7%
2018Q4	0.7	-44.1%	0.1	13.8%	-2.1	-309.6%	-293.4%
2018Q3	1.1	-0.9%	0.3	30.2%	-1.7	-157.8%	-89.5%
2018Q2	1.1	-4.4%	0.4	36.2%	-2.1	-181.9%	-80.5%
2018Q1	1.1	9.5%	0.4	30.8%	-1.7	-147.3%	-44.1%
2017Q4	1.2	33.2%	0.5	37.3%	-2.0	-158.9%	-129.4%
2017Q3	1.1	12.7%	0.4	35.1%	-1.7	-153.2%	-87.2%
2017Q2	1.2	14.4%	0.4	34.8%	-1.7	-145.2%	-82.6%
2017Q1	1.0	-0.3%	0.3	28.8%	-1.8	-172.4%	-107.5%
2016Q4	0.9	–	0.2	18.4%	-2.3	-246.7%	-138.7%
2016Q3	1.0	–	0.3	29.5%	-1.6	-165.2%	-150.4%